Telemedicine-Assisted Self-Management Program for Type 2 Diabetes Patients.

Source: von Storch, K., et al. 2019 - Pubmed ID: 31287736

Setting: Germany,

Study design:

RCT

Follow up: 3 months

Patient group:

Sample size:

Total: 2441 (115)

IG: 1541 (60)

CG: 900 (55)

Inclusion criteria:

– Diabetes type 2

– Age 40-67 years

Type of technology:

Tablet
– Data transfer
– Communication

Home monitoring equipment
– Glucometer
– Step counter

Telephone
– Guidance

Intervention:

Intervention: Tele medical devices served as a feedback tool for the patients to provide insight into the impact of behavior changes on their blood glucose levels. In each phone-based meeting, coach and participant developed and agreed on personal health goals that helped to better control the disease step by step. Phone calls at least every month.

Duration: 12 months

Add on: +

Control group:

Care as usual

Clinical effect/ Patient safety:

Clinical effect:

– HbA1c ↓

– Diabetes self-management ↑

– BMI ↓

– Physical activity →

Patient safety:

NA

Patient experiences/ Staff experiences:

Patient experiences:

NA

Staff experiences:

NA

Costs and organization:

Investment:

Material

– Tablet

– Glucometer

Running:

Staff resources

– telephone meeting

Organization:

NA

Health care utilization:

NA

Scroll to Top

Information

“↑”: Statistically significant increase

“↓”: Statistically significant decrease

“→”: Statistically insignificant (no difference)